ANDA 220590, held by Yichang Humanwell. Diltiazem Hydrochloride.
As of Nov 16, 2026, ANDA 220590 (Diltiazem Hydrochloride), held by Yichang Humanwell, was first approved by FDA on Sep 25, 2026, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 25, 2026 | Original application | Approved | None posted |
| Diltiazem Hydrochloride30MG · tablet;oral | Diltiazem Hydrochloride | Rx |
| Diltiazem Hydrochloride60MG · tablet;oral | Diltiazem Hydrochloride | Rx |
| Diltiazem Hydrochloride90MG · tablet;oral | Diltiazem Hydrochloride | Rx |
| Diltiazem Hydrochloride120MG · tablet;oral | Diltiazem Hydrochloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters